Ali Barzegar

Ali Barzegar


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2021 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
SJSahar Jafari
Sahar Jafari
EHErfan Hezaveh
Erfan Hezaveh
YJYahya Jalilpiran
Yahya Jalilpiran
AJAhmad Jayedi
Ahmad Jayedi
AWAlexei Wong
Alexei Wong
ABAli Barzegar
Ali Barzegar
We aimed to examine the association between adherence to plant-based diets (PBDs) and the risk of mortality among the general population. Relevant investigations were identified through PubMed, Scopus, Embase, and ISI Web of Knowledge. Data were pooled using a random-effects or a fixed-effects model. Twelve prospective cohort studies with 42,697 deaths among 508,861 participants were included. The hazard ratios (HRs) for the highest compared to the lowest category of adherence to the PBDs were 0.90 (95% confidence interval [CI]: 0.82, 0.99; I2 = 91%, n = 12) for all-cause and 0.77 (95% CI: 0.70, 0.86; I2 = 36%, n = 8) for coronary heart disease (CHD) mortality. Among PBDs subtypes, there was an inverse association between healthy plant-based 0.92 (95% CI: 0.88, 0.96; I2 = 0%, n = 2), Pesco-vegetarian 0.81 (95% CI: 0.70, 0.92; I2 = 0%, n = 2), and Pro-vegetarian 0.74 (95% CI: 0.55, 0.88; I2 = 61.2%, n = 2) diets and the risk of all-cause mortality. A vegetarian diet was also associated with lower risk of mortality due to cardiovascular 0.92 (95% CI: 0.85, 0.99; I2 = 0%, n = 5) and CHD 0.76 (95% CI: 0.68, 0.85; I2 = 35%, n = 7). Our findings show the potential protective role of PBDs against chronic disease mortality. As there were certain limitations in some of the studies included in this systematic review and meta-analysis, further research is necessary to confirm our findings.

17 March 2021 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Open access
PDF file
NRNima Radkhah
Nima Radkhah
SSSakineh Shab-Bidar
Sakineh Shab-Bidar
MZMeysam Zarezadeh
Meysam Zarezadeh
ASAbdolrasoul Safaeiyan
Abdolrasoul Safaeiyan
ABAli Barzegar
Ali Barzegar
Cardiovascular disease (CVD) is a leading cause of death around the world. According to the studies, apolipoproteins A1 and B100 play crucial role in CVD development and progression. Also, findings have indicated the positive role of vitamin D on these factors. Thus, we conducted the present meta-analysis of randomized controlled trials (RCTs) to demonstrate the impact of vitamin D supplementation on apolipoproteins A1 and B100 levels in adults. PubMed and Scopus databases and Google Scholar were searched up to 21 December 2020. Relevant articles were screened, extracted, and assessed for quality based on the Cochrane collaboration’s risk of bias tool. Data analysis conducted by random-effect model and expressed by standardized mean difference (SMD). The heterogeneity between studies was assessed by I-squared (I2) test. Subgroups and sensitivity Analyses were also conducted. Seven RCTs were identified investigating the impact of vitamin D on Apo A1 levels and six on Apo B100 levels. The findings showed the insignificant effect of vitamin D supplementation on Apo A1 (SMD=0.26 mg/dL; 95% confidence interval (CI), −0.10, 0.61; P= 0.155) and Apo B100 (standardized mean difference (SMD)=-0.06 mg/dL; 95% CI, −0.24, 0.12; P=0.530) in adults. There was a significant between-study heterogeneity in Apo A1 (I2=89.3%, P<0.001) and Apo B100 (I2=57.1%, P=0.030). However, significant increase in Apo A1 in daily dosage of vitamin D (SMD=0.56 mg/dL; 95% CI, 0.02, 1.11; P=0.044) and ≤12 weeks of supplementation duration (SMD=0.71 mg/dL; 95% CI, 0.08, 1.34; P=0.028) was observed. No significant effects of vitamin D on Apo A1 and Apo B100 levels after subgroup analysis by mean age, gender, study population, dosage and duration of study. Overall, daily vitamin D supplementation and ≤12 weeks of supplementation might have beneficial effects in increasing Apo A1 levels, however, future high-quality trials considering these a primary outcome are required.

17 February 2014 in Health Scope
Verified
Journal Article
Open access
PDF file
BABeitullah Alipour
Beitullah Alipour
ABAli Barzegar
Ali Barzegar
FPFarid Panahi
Farid Panahi
ASAbdolrasol Safaeian
Abdolrasol Safaeian
MEMasoud Es.HAghi
Masoud Es.HAghi
Background: More than 500 million people worldwide are obese and around 320 million adults have type II diabetes, thus these two diseases are accounted as the fundamental health care problems. There is such a strong association between obesity and diabetes that the term diabesity is proposed for this connection. Since anti-obesity drugs have many side effects, experts have very few tools to fight obesity, while high doses of carnitine has no side effects compared to other drugs. Objectives: The current study aimed to evaluate the effect of L-carnitine supplementation with low-calorie diet on the metabolic status in obese women with type II diabetes. Patients and Methods: In this study, 60 obese premenopausal women with type II diabetes were randomly selected from the patients who referred to the Diabetes Clinic of Tabriz Red Crescent; they were 20 - 50 years old with a BMI greater than 30. The subjects were divided into two groups, case and control. Following the measurement of weight, waist circumference and recording personal information, weekly food intake program (based on a low calorie diet) was given to patients. For about 8 weeks, the case group received L-carnitine supplement (2 grams daily) combined with the low calorie diet, and the control group received placebo plus low-calorie diet. In this study, low calorie diet was defined as a regimen of 500 kcal lower than the patients required energy. Blood samples (5 mL of venous blood) were taken from all patients in the sitting position, and in fasting condition (for about 10 - 12 hours) between 7:00 AM and 9:00 AM. After separation of plasma by centrifugation for ten minutes in 3000 g, samples were analyzed to measure fasting blood glucose, lipid profile and insulin resistance. Results: The results showed that L-carnitine supplement with low calorie diet reduced fasting blood glucose, triglycerides, cholesterol and LDL-C (Cholesterol, LDL-cholesterol) levels and decreased insulin resistance "HOMA-IR" (P < 0.0001), whereas in the control group, reduction of fasting blood glucose and triglycerides, cholesterol and LDL-C levels and decrease of insulin resistance "HOMA-IR" were lower than those of the case group (P < 0.05). Conclusions: Due to the effect of L-carnitine supplementation (a dose of 1000 mg twice daily) with low-calorie diet on reduction of fasting blood glucose, triglycerides, cholesterol and LDL-C levels and insulin resistance (HOMA-IR), prescribing this supplement in obese patients with diabetes is recommended. Keywords: Carnitine; Diabetes Mellitus; Insulin Resistance; Diet Therapy; Metabolic Syndrome X

21 May 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
JSJafar Sadeghzadeh
Jafar Sadeghzadeh
JJJaber Jafarzadeh
Jaber Jafarzadeh
PHPezhman Hadinezhad
Pezhman Hadinezhad
ANAhmad Nazari
Ahmad Nazari
SSSaeedeh Sohrabi
Saeedeh Sohrabi
PSParviz Shahabi
Parviz Shahabi

14 May 2020 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SASanaz Asemani
Sanaz Asemani
VMVahid Montazeri
Vahid Montazeri
MFMitra Foroutan-Ghaznavi
Mitra Foroutan-Ghaznavi
SPSeyed-Sajjad Pirouzpanah
Seyed-Sajjad Pirouzpanah
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
SPSaeed Pirouzpanah
Saeed Pirouzpanah
We aimed to study dietary patterns in association with the relative expression levels of PPAR-γ, vascular endothelial growth factor-A (VEGF-A) and hypoxia-inducible factor-1α (HIF-1α) in women with benign breast disease (BBD). The study design was combinative, included a case-series and case–control compartments. Initially, eligible BBD patients (n 77, aged 19–52 years old) were recruited at Nour-Nejat hospital, Tabriz, Iran (2012–2014). A hospital-based group of healthy controls was matched for age (n 231, aged 20–63 years old) and sex. Dietary data were collected using a valid 136-item FFQ. Principal component analysis generated two main components (Kaiser–Meyer–Olkin = 0·684), including a Healthy pattern (whole bread, fruits, vegetables, vegetable oils, legumes, spices, seafood, low-fat meat, skinless poultry, low-fat dairy products, nuts and seeds) and a Western pattern (starchy foods, high-fat meat and poultry, high-fat dairy products, hydrogenated fat, fast food, salt and sweets). High adherence to the Western pattern increased the risk of BBD (ORadj 5·59; 95 % CI 2·06, 15·10; P < 0·01), whereas high intake of the Healthy pattern was associated with a 74 % lower risk of BBD (95 % CI 0·08, 0·81; P < 0·05). In the BBD population, the Western pattern was correlated with over-expression of HIF-1α (radj 0·309, P < 0·05). There were inverse correlations between the Healthy pattern and expressions of PPAR-γ (radj −0·338, P < 0·05), HIF-1α (radj −0·340, P < 0·05) and VEGF-A (radj −0·286, P < 0·05). In conclusion, new findings suggested that the Healthy pattern was associated inversely with the risk of BBD, and this could be correlated with down-regulation of PPAR-γ, VEGF-A and HIF-1α genes, which might hold promise to preclude BBD of malignant pathological transformation.

2 July 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SDSepideh Dolati
Sepideh Dolati
ABAli Barzegar
Ali Barzegar
FMFatemeh Mohammadi-Nasrabadi
Fatemeh Mohammadi-Nasrabadi
MAMorteza Abdollahi
Morteza Abdollahi
RKRahim Khodayari-Zarnaq
Rahim Khodayari-Zarnaq
:: Poor nutrition in pregnancy is a common cause of maternal and infant mortality and morbidity, low birth weight and intrauterine growth retardation (IUGR). Cash transfer support programs for impoverished and nutritionally vulnerable pregnant mothers positively impact maternal and fetal health, decrease the prevalence of low birth weight, and reduce infant mortality rates…The objective of this study was to examine the impact of a cash transfer program on the weight gain and anemia status of pregnant mothers, as well as the birth weight and growth rate of their infants in Iran. A retrospective field trial study was conducted in 4 regions of Iran: Ardabil, Jiroft, Kerman, and Abadan. Of pregnant mothers, 432 were randomly selected and placed into two groups: the cash transfer (intervention) and the eligible non-supported (control group). The intervention group received 250,000 Toman (approximately 21 USD) cash transfers every two months, from the fourth month of pregnancy to sixth months after giving birth. Maternal age, education, and occupation, the occupation of the household head, pre-pregnancy BMI, maternal weight gain, and hemoglobin levels at the 4th and 8th months of pregnancy, birth weight, infants’ head circumference and weight trends at 2, 4, and 6 months were recorded. Chi-square, paired t-test, and repeated measurement ANOVA were used by IBM SPSS. Maternal hemoglobin levels significantly decreased in both groups by the 8th month of pregnancy compared to the 4th month. The prevalence of anemia increased in both groups, but the increase was significantly smaller in the intervention group (32.5% vs. 42.2%, p = 0.024). Undesirable weight gain was reduced in both groups, with a more significant reduction in the intervention group (36.0% vs. 50.5%, p = 0.042). Birth weight (3056.9 ± 492.2 gr vs. 2921.3 ± 505.5 gr) and weight at 2 months (4946.2 ± 868.8 gr vs. 4697.2 ± 947.3 gr) were significantly higher in the cash transfer group compared to the control group (p = 0.005). The interaction between time and group on infant weight gain was statistically significant (p = 0.012). Implementing a cash transfer program can lead to improved weight gain during pregnancy, more appropriate birth weights for infants, and better weight gain at 2 months. Given the positive impact of cash transfer programs on maternal and child health indicators, further studies are needed to address the challenges faced by these support programs.